| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 06/02/2022 | 42.91% | Wolfe Research | $238 → $231 | Maintains | Outperform |
| 12/15/2021 | 23.73% | Morgan Stanley | $230 → $200 | Downgrades | Overweight → Equal-Weight |
| 11/01/2021 | 42.29% | Morgan Stanley | $220 → $230 | Maintains | Overweight |
| 01/19/2021 | 36.1% | Morgan Stanley | $210 → $220 | Maintains | Overweight |
| 01/11/2021 | 38.58% | Barclays | → $224 | Initiates Coverage On | → Overweight |
| 07/30/2020 | 29.92% | Morgan Stanley | → $210 | Initiates Coverage On | → Overweight |
| 05/13/2020 | 18.78% | Imperial Capital | $194 → $192 | Maintains | Outperform |
Madison Square Garden Questions & Answers
The latest price target for Madison Square Garden (NYSE: MSGS) was reported by Wolfe Research on June 2, 2022. The analyst firm set a price target for $231.00 expecting MSGS to rise to within 12 months (a possible 42.91% upside). 3 analyst firms have reported ratings in the last year.
The latest analyst rating for Madison Square Garden (NYSE: MSGS) was provided by Wolfe Research, and Madison Square Garden maintained their outperform rating.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Madison Square Garden, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Madison Square Garden was filed on June 2, 2022 so you should expect the next rating to be made available sometime around June 2, 2023.
While ratings are subjective and will change, the latest Madison Square Garden (MSGS) rating was a maintained with a price target of $238.00 to $231.00. The current price Madison Square Garden (MSGS) is trading at is $161.64, which is out of the analyst's predicted range.